Although these biomarkers are of some help to the management of individual patients, these tools are not ideal because the differences between the responder groups and non-responder groups are usually small and overlap between the groups is quite significant.
← all excerpts
Identification of serum proteins and multivariate models for diagnosis and therapeutic monitoring of lung cancer.
1
—
—